Log in to save to my catalogue

Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer

Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2479186987

Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer

About this item

Full title

Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer

Publisher

London: Nature Publishing Group UK

Journal title

Signal transduction and targeted therapy, 2021-01, Vol.6 (1), p.26-12, Article 26

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Neoantigens are considered to be ultimate target of tumor immunotherapy due to their high tumor specificity and immunogenicity. Dendritic cell (DCs) vaccines based on neoantigens have exciting effects in treatment of some malignant tumors and are a promising therapeutic modality. Lung cancer is a lethal disease with the highest morbidity and mortal...

Alternative Titles

Full title

Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2479186987

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2479186987

Other Identifiers

ISSN

2059-3635,2095-9907

E-ISSN

2059-3635

DOI

10.1038/s41392-020-00448-5

How to access this item